Company intelligence / Profile preview

Oximio

Huntingdon, Cambridgeshire, United Kingdomzoominfo.com ↗

Ownership: Private
Development stage: Commercial

Overview

Oximio (formerly known as SMO Group) is a global clinical trial logistics and services provider. The company specializes in supporting pharmaceutical companies, CROs, CMOs, and R&D organizations with comprehensive clinical trial supply chain solutions. Their offerings include regulatory support, import/export management of investigational medicinal products (IMPs), customs clearance expertise, warehousing and distribution for clinical trials across multiple geographies. They are recognized for their deep local expertise in Ukraine and have expanded operations to Israel and Georgia. In 2021 the company rebranded from "SMO Group" to "Oximio" to reflect its global growth.

Industry: Contract Research Organization

Partnerships

Works with major international CROs/CMOs/pharmaceutical companies

Beyond the preview

Go deeper on Oximio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oximio.

Explore the full profile